🇺🇸 Mycophenolate Mofetil Cap./Tab. in United States

1 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 1

Most-reported reactions

1. Fatigue — 1 report (100%)

Source database →

Frequently asked questions

Is Mycophenolate Mofetil Cap./Tab. approved in United States?

Mycophenolate Mofetil Cap./Tab. does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Mycophenolate Mofetil Cap./Tab. in United States?

Chong Kun Dang Pharmaceutical is the originator. The local marketing authorisation holder may differ — check the official source linked above.